At the meeting in Budapest the Council approved the proposal of the Royal Society for Chemistry to jointly launch MedChemComm.

By Gerhard Ecker

and also read the Editorial...

By Gabriele Costantino

Virtual Screening: What Are We Missing?

Virtual screening is an established concept for hit and subsequent lead candidate identification during the early phases of a drug discovery project. Despite the high number of successful applications published over the last years, the current prediction software solutions (e.g., for "drug-likeness", pharmacokinetic parameters, target-ligand binding) rarely exceed 80-85% accuracy at best in retrospective tests, and 40-50% as an optimistic estimate in prospective applications. So, what’s missing?

By Gisbert Schneider

The Department of Biomolecular Systems – Max-Planck Institute for Colloids and Surfaces, Potsdam

The Department for Biomolecular Systems, founded in 2009, conducts research at the interface of chemistry, engineering, biology, immunology and medicine.

By Peter Seeberger

The offer of sponsored meetings, schools and short courses is very high. Don’t miss the most important event of this year.